Cargando…
Microspherical Particles of Solid Dispersion of Polyvinylpyrrolidone K29-32 for Inhalation Administration
Inhalation administration is a promising alternative to the invasive drug delivery methods. The particle size required for ideal drug aerosol preparation is between 1 and 3 μm. The application of microspherical particles of solid dispersions enhances bioavailability of poorly soluble drugs due to th...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818905/ https://www.ncbi.nlm.nih.gov/pubmed/29546051 http://dx.doi.org/10.1155/2018/2412156 |
_version_ | 1783301105862574080 |
---|---|
author | Usmanova, L. S. Ziganshin, M. A. Rakipov, I. T. Lyadov, N. M. Klimovitskii, A. E. Mukhametzyanov, T. A. Gerasimov, A. V. |
author_facet | Usmanova, L. S. Ziganshin, M. A. Rakipov, I. T. Lyadov, N. M. Klimovitskii, A. E. Mukhametzyanov, T. A. Gerasimov, A. V. |
author_sort | Usmanova, L. S. |
collection | PubMed |
description | Inhalation administration is a promising alternative to the invasive drug delivery methods. The particle size required for ideal drug aerosol preparation is between 1 and 3 μm. The application of microspherical particles of solid dispersions enhances bioavailability of poorly soluble drugs due to the solubilization. In the present work, the spray drying process of the production of microspherical particles of solid dispersions of polyvinylpyrrolidone K29-32 with model hydrophobic drug, phenacetin, was optimized using the results of DSC, PXRD, and viscometry. The diameter of the obtained particles is within 1–3 μm range. The Gibbs energy of dissolution in water was shown to be negative for the mixture with polymer/phenacetin mass ratio 5 : 1. We have demonstrated that the optimal size distribution for the inhalation administration is obtained for microspherical particles produced using spray caps with 7.0 μm hole size. The dissolution rates of phenacetin from the produced microspherical particles were faster than that of drug powder. As evidenced by powder X-ray diffraction data, phenacetin stayed in amorphous state for 4 months in microspherical particles of solid dispersions. According to the obtained results, strategic application of the spray drying process could be beneficial for the improvement of the pharmaceutical properties of model drug, phenacetin. |
format | Online Article Text |
id | pubmed-5818905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-58189052018-03-15 Microspherical Particles of Solid Dispersion of Polyvinylpyrrolidone K29-32 for Inhalation Administration Usmanova, L. S. Ziganshin, M. A. Rakipov, I. T. Lyadov, N. M. Klimovitskii, A. E. Mukhametzyanov, T. A. Gerasimov, A. V. Biomed Res Int Research Article Inhalation administration is a promising alternative to the invasive drug delivery methods. The particle size required for ideal drug aerosol preparation is between 1 and 3 μm. The application of microspherical particles of solid dispersions enhances bioavailability of poorly soluble drugs due to the solubilization. In the present work, the spray drying process of the production of microspherical particles of solid dispersions of polyvinylpyrrolidone K29-32 with model hydrophobic drug, phenacetin, was optimized using the results of DSC, PXRD, and viscometry. The diameter of the obtained particles is within 1–3 μm range. The Gibbs energy of dissolution in water was shown to be negative for the mixture with polymer/phenacetin mass ratio 5 : 1. We have demonstrated that the optimal size distribution for the inhalation administration is obtained for microspherical particles produced using spray caps with 7.0 μm hole size. The dissolution rates of phenacetin from the produced microspherical particles were faster than that of drug powder. As evidenced by powder X-ray diffraction data, phenacetin stayed in amorphous state for 4 months in microspherical particles of solid dispersions. According to the obtained results, strategic application of the spray drying process could be beneficial for the improvement of the pharmaceutical properties of model drug, phenacetin. Hindawi 2018-01-10 /pmc/articles/PMC5818905/ /pubmed/29546051 http://dx.doi.org/10.1155/2018/2412156 Text en Copyright © 2018 L. S. Usmanova et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Usmanova, L. S. Ziganshin, M. A. Rakipov, I. T. Lyadov, N. M. Klimovitskii, A. E. Mukhametzyanov, T. A. Gerasimov, A. V. Microspherical Particles of Solid Dispersion of Polyvinylpyrrolidone K29-32 for Inhalation Administration |
title | Microspherical Particles of Solid Dispersion of Polyvinylpyrrolidone K29-32 for Inhalation Administration |
title_full | Microspherical Particles of Solid Dispersion of Polyvinylpyrrolidone K29-32 for Inhalation Administration |
title_fullStr | Microspherical Particles of Solid Dispersion of Polyvinylpyrrolidone K29-32 for Inhalation Administration |
title_full_unstemmed | Microspherical Particles of Solid Dispersion of Polyvinylpyrrolidone K29-32 for Inhalation Administration |
title_short | Microspherical Particles of Solid Dispersion of Polyvinylpyrrolidone K29-32 for Inhalation Administration |
title_sort | microspherical particles of solid dispersion of polyvinylpyrrolidone k29-32 for inhalation administration |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818905/ https://www.ncbi.nlm.nih.gov/pubmed/29546051 http://dx.doi.org/10.1155/2018/2412156 |
work_keys_str_mv | AT usmanovals microsphericalparticlesofsoliddispersionofpolyvinylpyrrolidonek2932forinhalationadministration AT ziganshinma microsphericalparticlesofsoliddispersionofpolyvinylpyrrolidonek2932forinhalationadministration AT rakipovit microsphericalparticlesofsoliddispersionofpolyvinylpyrrolidonek2932forinhalationadministration AT lyadovnm microsphericalparticlesofsoliddispersionofpolyvinylpyrrolidonek2932forinhalationadministration AT klimovitskiiae microsphericalparticlesofsoliddispersionofpolyvinylpyrrolidonek2932forinhalationadministration AT mukhametzyanovta microsphericalparticlesofsoliddispersionofpolyvinylpyrrolidonek2932forinhalationadministration AT gerasimovav microsphericalparticlesofsoliddispersionofpolyvinylpyrrolidonek2932forinhalationadministration |